Novo CEO pressed by Senate to chop costs of being overweight, diabetic issues medication CEO Lars Fruergaard Jørgensen advised lawmakers the organization would look at new talks with insurers concerning the listing prices of Wegovy and copyright should they pledge to maintain the medicines on their own formularies. Elevance lowers https://kethek.com/